Table 1.
Demographic data and clinical investigations of 133 HCV infected patients.
| Variables | 133 chronic HCV patients |
|---|---|
| Age (years) | 42.5 ± 9.7 |
| BMI (Kg/m2) | 27.1 ± 4.0 |
| Hemoglobin (g/dL) | 13.9 ± 1.6 |
| Platelet count (10³/μL) | 216 ± 67.2 |
| Baseline ALT (IU/L) | 68.3 ± 42.9 |
| Baseline AST (IU/L) | 55.6 ± 37.4 |
| Total bilirubin (mg/dL) | 0.62 ± 0.39 |
| Total leukocytic count (10³/μL) | 6.08 ± 2.08 |
|
| |
| Gender | |
| Male | 91 (68.4%) |
| Female | 42 (31.6%) |
|
| |
| AFP (cut off) | |
| ≤4.5 (ng/mL) | 83 (62.4%) |
| >4.5 (ng/mL) | 50 (37.6%) |
|
| |
| HCV viral load | |
| <600,000 IU/mL | 80 (60.1%) |
| ≥600,000 IU/mL | 53 (39.9%) |
|
| |
| Liver histology (METAVIR) | |
| F (n: 0/1/2/3/4) | 2/59/29/36/7 |
| A (n: 0/1/2/3) | 7/81/33/12 |
BMI: body mass index; ALT: alanine aminotransferase; AST: aspartate amino transferase; AFP: alpha-fetoprotein; F: liver fibrosis stage; A: liver activity grade.